EISAI
Eisai is a human health care company that provides products and services to its patients and their families under any healthcare system. Eisai specializes in the integrated pharmaceutical business that operates in business groups it focuses on oncology and neurology, dementia-related diseases and neurodegenerative diseases. The company was founded in 1941 and headquartered in Tokyo, Japan.
EISAI
Industry:
Biotechnology Health Care Health Insurance Pharmaceutical
Founded:
1941-12-06
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.eisai.co.jp
Total Employee:
10001+
Status:
Active
Contact:
81-3-3817-3700
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Apache Global Site Tag
Similar Organizations
Advantage Risk Management
Advantage Risk Management is a mental health care company that provides comprehensive mental health services for companies.
Eisai Europe
Eisai Europe is a human health care company that provides products and services to its patients.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
UNI PHARMA
Unipharma is to provide healthcare products and outstanding services for both pharmaceutical and animal healthcare products.
Current Employees Featured
Yuji Matsue Chairman & CEO @ Eisai
Chairman & CEO
Wil Foster Director Regulatory Affairs @ Eisai
Director Regulatory Affairs
Haruo Naito CEO @ Eisai
CEO
Yasushi Okada COO @ Eisai
COO
Chad Swanson Executive Director, Neurology Business Group; Clinical Research @ Eisai
Executive Director, Neurology Business Group; Clinical Research
2019-07-01
Eran Nadav Business Development Director @ Eisai
Business Development Director
Stewart Geary Deputy Director @ Eisai
Deputy Director
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2010-01-07 | AkaRx | AkaRx acquired by Eisai | 255 M USD |
| 2007-03-22 | Morphotek | Morphotek acquired by Eisai | 325 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-09 | LIFENET INSURANCE COMPANY | Eisai investment in Post-IPO Equity - LIFENET INSURANCE COMPANY | 300 M JPY |
| 2022-01-27 | Ractigen Therapeutics | Eisai investment in Series A - Ractigen Therapeutics | 30 M USD |
| 2021-09-09 | Neuroglee Therapeutics | Eisai investment in Series A - Neuroglee Therapeutics | 10 M USD |
| 2021-05-04 | ŌURA | Eisai investment in Series C - ŌURA | 100 M USD |
| 2021-04-05 | Allm | Eisai investment in Series A - Allm | 5.6 B JPY |
| 2020-12-03 | Neuroglee Therapeutics | Eisai investment in Pre Seed Round - Neuroglee Therapeutics | 2.3 M USD |
| 2020-11-05 | Unlearn.AI | Eisai investment in Series A - Unlearn.AI | 3 M USD |
| 2020-04-10 | Darmiyan | Eisai investment in Seed Round - Darmiyan | 6.43 M USD |
| 2019-12-12 | Numab | Eisai investment in Series B - Numab | 22 M CHF |
| 2019-05-09 | Allm | Eisai investment in Corporate Round - Allm | N/A |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-27 | Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership |
Official Site Inspections
http://www.eisai.co.jp Semrush global rank: 333.99 K Semrush visits lastest month: 181.62 K
Unable to get host informations!!!
More informations about "Eisai"
エーザイ株式会社｜ヒューマン・ヘルスケアのエーザイ
エーザイ株式会社の企業サイトです。株主・投資家の皆さまへ、ヒューマン・ヘルスケア（hhc）、サステナビリティ、会社 ...See details»
Eisai Group Worldwide | Corporate Information | Eisai Co., Ltd.
Eisai Europe Ltd. EMEA Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, U.K. Tel: 44-208-600-1400 European headquarters / holding company, pharmaceutical salesSee details»
Eisai at a Glance | About Eisai - Eisai Co., Ltd.
Eisai is promoting initiatives for improving access to medicines in developing and emerging countries. Eisai is committed to supplying tablets free of charge from its Vizag Plant in India to …See details»
[エーザイ全社組織図] - エーザイ株式会社
[エーザイ全社組織図] - エーザイ株式会社See details»
Org Chart Eisai - The Official Board
Organizational Chart of Eisai. Eisai www.eisai.co.jp. has 102 executives and 12 subsidiaries +81 338 173 700; Add an executive. Eisai (4523) News . Anything missing? We search for you. …See details»
» Eisai Worldwide
Eisai has more than 10,000 employees worldwide and is a publicly traded company whose stock trades on the Tokyo Stock Exchange and is listed in the United States under an American …See details»
Eisai Australia
Our work at Eisai prioritises patients and their families through our focus to continually improve the benefits that health care can provide. We call this human health care (hhc) Eisai in …See details»
Corporate values and responsibilities | Eisai US
INTEGRITY AT EISAI: ROOTED IN ALL WE DO. Integrity is a core value to the Eisai organization. What we mean by integrity is that we strive as a Company to be honest and …See details»
Eisai - The Org
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical …See details»
Eisai Co., Ltd.｜A human health care company
Notice Concerning Commencement of Tender Offer by Eisai Co., Ltd. for Share Certificates, etc., of EcoNaviSta Inc. (Securities Code: 5585) March 10, 2025. EISAI RECOGNIZED AS “2025 …See details»
Eisai - Crunchbase Company Profile & Funding
Eisai is a human healthcare company that provides products and services to its patients and their families under any healthcare system. They specialize in an integrated pharmaceutical …See details»
Meet the inspiring leadership team | Eisai US
In 2020, Mr. Yasuno returned to the U.S. as President of Eisai Inc. and the Americas Region, successfully navigating the business and leading the organization through the critical …See details»
[Eisai Corporate Organization Chart]
[Eisai Corporate Organization Chart]See details»
Our History | Eisai Europe
Eisai co-establishes the Global Health Innovative Technology Fund (GHIT Fund), Japan's first public–private partnership to advance development of new health technologies for the …See details»
Eisai Selected as a Nadeshiko Brand 2025 as a Listed Company …
14 hours ago TOKYO, Mar 25, 2025 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has been selected by the Ministry of Economy, Trade and Industry (METI) and the Tokyo …See details»
About Eisai - Eisai Co., Ltd.
Welcome to the Eisai Official Corporate Website About Eisai Page.See details»
Eisai Selected as a Nadeshiko Brand 2025 as a Listed Company …
14 hours ago TOKYO, Mar 25, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has been selected by the Ministry of Economy, Trade and Industry (METI) and the Tokyo …See details»
Eisai: The First 80 Years - Eisai Co., Ltd.
Eisai signs a statement with the World Health Organization (WHO) to supply a primary lymphatic filariasis medicine free of charge. H3 Biomedicine Inc. is established as a research subsidiary …See details»
Corporate Executives | Corporate Information | Eisai Co., Ltd.
Jun 14, 2024 Chairman & CEO, Eisai Europe Ltd. Tatsuyuki Yasuno. Senior Vice President President, Americas Region Chairman & CEO, Eisai Inc. Yanhui Feng. Senior Vice President …See details»
EISAI RECOGNIZED AS “2025 KENKO INVESTMENT FOR HEALTH” …
For Print; March 10, 2025; Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has been recognized as the 2025 KENKO Investment for Health by …See details»